Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib vs Tocilizumab in Rheumatoid Arthritis (TRANSFORM)
NCT05090410Phase 3Unknown
- Sponsor
- Atsushi Kawakami
- Start
- Mar 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of filgotinib in rheumatoid arthritis (RA), sponsored by Atsushi Kawakami. Status: unknown.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05090410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05090410.